Specialized Disclosure Report (sd)
May 21 2020 - 4:45PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM SD
Specialized Disclosure Report
ABIOMED, Inc.
(Exact Name of Registrant as Specified in its Charter)
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
|
001-09585
|
|
04-2743260
|
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
|
|
|
|
|
|
|
22 Cherry Hill Drive, Danvers, Massachusetts
|
|
01923
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Todd A. Trapp
978-646-1400
(Name and telephone number, including area code, of the person to contact in connection with this report)
Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:
|
|
|
|
☒
|
Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2019.
|
Section 1 — Conflict Minerals Disclosure
|
|
|
|
Item 1.01
|
Conflict Minerals Disclosure and Report
|
Conflict Minerals Disclosure
This Form SD of ABIOMED, Inc. (the “Company”) is filed pursuant to Rule 13p-1 promulgated under the Securities Exchange Act of 1934, as amended, for the reporting period from January 1, 2019 to December 31, 2019.
A copy of our Conflict Minerals Report is filed herewith as Exhibit 1.01 hereto and is publicly available at: www.abiomed.com.
Information appearing on www.abiomed.com is not a part of, and is not incorporated by reference into, this Form SD.
The Company is hereby filing its Conflict Minerals Report described in Item 1.01 as Exhibit 1.01 to this Report.
Section 2 — Exhibits
The following exhibit is filed as part of this report:
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
Date: May 21, 2020
|
|
ABIOMED, INC.
(Registrant)
|
|
|
|
|
|
|
|
By:
|
|
/s/ Todd A. Trapp
|
|
|
|
|
|
|
|
|
|
|
|
Todd A. Trapp
Vice President, Chief Financial Officer
|
|
|
|
|
|
|
ABIOMED (NASDAQ:ABMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
ABIOMED (NASDAQ:ABMD)
Historical Stock Chart
From Apr 2023 to Apr 2024
